2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Saturday, October 6, 2018

1:45pm-3:15pm: Correlation between cerebral perfusion and striatal dopamine transporter activity by dual SPECT study in Parkinsonian syndromes

Y. Nakano, S. Hirano, K. Kojima, H. Li, A. Ishikawa, T. Sakurai, H. Tai, H. Mukai, T. Horikoshi, T. Uno, S. Kuwabara (Chiba, Japan)

Neuroimaging (Non-PD) · Hall 3FG

1:45pm-3:15pm: Correlation between severity of disease, spatio-temporal variables, and kinematic variables during forward and backward walking

M. Son, C. Youm, M. Lee, H. Park (Busan, Republic of Korea)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Cortical myoclonus explained by cerebellar dysfunction: Evidence from a unique case

L. Rocchi, L. Latorre, J. Rothwell, K. Bhatia (London, United Kingdom)

Neurophysiology (Non-PD) · Hall 3FG

1:45pm-3:15pm: Cortical thinning as a neuroimaging marker of cognitive decline in X-linked dystonia-parkinsonism

J. Prasuhn, H. Hanßen, A. Domingo, C. Diesta, R. Rosales, R. Jamora, C. Klein, N. Brüggemann (Luebeck, Germany)

Neuroimaging (Non-PD) · Hall 3FG

1:45pm-3:15pm: Corticomuscular and Intermuscular Coherence as a Biomarker of Pallidal Deep Brain Stimulation Efficacy in Dystonia

E. Doldersum, J. van Zijl, M. Beudel, H. Eggink, R. Brandsma, D. Pina Fuentes, M. van Egmond, D. Oterdoom, J. van Dijk, J. Elting, M. de Koning-Tijssen (Groningen, Netherlands)

Surgical Therapy: Other Movement Disorders · Hall 3FG

1:45pm-3:15pm: Could curcumin be the preventive key of parkinson’s disease?

W. Laabbar, A. Elgot, H. Gamrani (Marrakech, Morocco)

Neuropharmacology · Hall 3FG

1:45pm-3:15pm: Could the rate of dopaminergic medications reduction affect outcome after STN-DBS?

S. Alusi (Liverpool, United Kingdom)

Surgical Therapy: Parkinson's Disease · Hall 3FG

1:45pm-3:15pm: Crack Dancing: An Uncommon Drug-Induced Chorea

G. Gibb, D. Nacopoulos (Erie, PA, USA)

Drug-Induced Movement Disorders · Hall 3FG

1:45pm-3:15pm: Deep brain stimulation (DBS) for dyskinetic cerebral palsy: A pilot study

S. Duma, N. Mahant, A. Ha, S. Kim, A. Phu, K. Stewart, M-C. Waugh, N. Wolfe, D. Russell, B. Owler, M. Krause, V. Fung (Westmead, Australia)

Clinical Trials and Therapy in Movement Disorders · Hall 3FG

1:45pm-3:15pm: Deep brain stimulation and its efficacy using microelectrode recording

V. Rama Raju, R. Borgohain (Hyderabad, India)

Surgical Therapy: Parkinson's Disease · Hall 3FG